Bifidobacterium Longum Drug Interactions, Uses, Effectiveness, Safety & More
What is this page for?
First and foremost: how Bifidobacterium Longum interacts with medications. The heart of this page is the interaction list — every drug Bifidobacterium Longum is known to interact with, and how serious each one is.
But these pages have grown well beyond that into a full monograph — what Bifidobacterium Longum is, what people use it for and how strong the evidence is, its safety and side effects, and answers to the questions we’re asked most — written and reviewed by the clinical staff at HelloPharmacist. It’s educational information from our licensed clinical databases, not medical advice, and we don’t sell or endorse products. Our editorial policy
Check Bifidobacterium Longum against your medication
Add one medicationDrugs that interact with Bifidobacterium Longum
182 medications have a known interaction with Bifidobacterium Longum, graded by severity. Select any drug for the full evidence-based detail.
Don’t want to scroll the list? Just ask.
Tell us the medications you take and we’ll check each one against Bifidobacterium Longum using our pharmacist-reviewed interaction data.
AI summaries are generated from our Bifidobacterium Longum interaction data for education only — always confirm with your pharmacist. How we use AI
No drugs match “”.
What Severity, Likelihood & Evidence Mean
Severity — How Serious It Can Be
- Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
- Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
- Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
- No known interaction. Checked against our sources with nothing documented — not the same as proven safety.
Likelihood — How Well It’s Documented
- Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
- Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
- Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Where This Data Comes From
- Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
- Each drug listed above links to the full report for that exact Bifidobacterium Longum combination — clinical detail, likelihood, evidence level, and citations.
- Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The kinds of drugs Bifidobacterium Longum affects
Every type of medication (drug category) Bifidobacterium Longum is known to interact with. Open any category for the detail — or search your exact drug in the checker above.
Antibiotic Drugs
Theoretically, taking Bifidobacterium longum with antibiotic drugs might decrease the effectiveness of B. longum.
Since B. longum preparations usually contain live and active organisms, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and B. longum preparations by at least 2 hours.
Bifidobacterium Longum: Uses, Safety & Side Effects
Bifidobacterium longum is a 'friendly' bacterium found naturally in the human gut and used as a probiotic. It is generally well tolerated and is most studied for digestive issues, though evidence for many uses is still limited or mixed. Talk to your pharmacist or doctor before using it, especially if you have a weakened immune system.
- Scientific name
- Bifidobacterium longum
- Family
- Bifidobacteriaceae
- Part used
- Live bacterial cells (probiotic)
- Common forms
- Capsules, tablets, powders, sachets, fermented foods, and multi-strain probiotic blends
- Digestive health and regularity
- Irritable bowel syndrome (IBS)
- Diarrhea (including antibiotic-related)
- Immune support
- Mood and stress (gut-brain axis)
Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.
Generally well tolerated in healthy people, but caution is needed for those who are seriously ill or immune-compromised.
When used orally and appropriately, short-term. A combination of Bifidobacterium longum and Lacticaseibacillus rhamnosus has been used with apparent s...
Read the full pregnancy detailWhen used orally and appropriately, short-term. A combination of Bifidobacterium longum and Lacticaseibacillus rhamnosus has been used with apparent s...
Read the full breastfeeding detailPregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Overview
Bifidobacterium longum is a type of beneficial bacteria that lives naturally in the human digestive tract. It is one of the first bacteria to colonize the gut of newborns, especially breastfed babies, and it remains an important part of a healthy gut microbiome throughout life.
As a supplement, B. longum is grown in controlled conditions and sold as a probiotic. It comes alone or, more often, combined with other probiotic strains. You can find it in capsules, powders, sachets, and some fermented foods or dairy products.
People take B. longum mainly to support digestive health, but it is also marketed for immune support and, more recently, for mood and stress through the so-called 'gut-brain axis.'
How it works
As a probiotic, Bifidobacterium longum is thought to work by adding helpful bacteria to the gut. Proposed mechanisms include crowding out harmful bacteria, producing short-chain fatty acids that nourish the gut lining, and helping keep the gut barrier healthy.
It may also interact with the immune system in the gut and influence signals that travel between the gut and the brain. Much of this understanding comes from laboratory and animal studies, so how strongly these effects apply to people is still being worked out.
Does Bifidobacterium Longum work?
How to read these evidence grades
Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.
For Bifidobacterium Longum, current evidence isn’t strong enough to rate any specific use. The conditions it has been studied for are listed below.
Also studied for 49 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Abdominal pain
It is unclear if oral Bifidobacterium longum is beneficial for abdominal pain or discomfort.
Insufficient Reliable Evidence To Rate Acute kidney injury (AKI)
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Acute radiation syndrome
It is unclear if oral Bifidobacterium longum is beneficial for acute radiation syndrome.
Insufficient Reliable Evidence To Rate Age-related cognitive decline
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Allergic rhinitis (hay fever)
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Antibiotic-associated diarrhea
It is unclear if oral Bifidobacterium longum is beneficial for preventing antibiotic-associated diarrhea (AAD); the available research is conflicting.
Insufficient Reliable Evidence To Rate Asthma
It is unclear if oral Bifidobacterium longum is beneficial for asthma.
Insufficient Reliable Evidence To Rate Athletic performance
It is unclear if oral Bifidobacterium longum is beneficial for athletic performance.
Insufficient Reliable Evidence To Rate Atopic dermatitis (eczema)
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Attention deficit-hyperactivity disorder (ADHD)
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Bronchopulmonary dysplasia
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Cancer
Although there has been interest in using oral Bifidobacterium longum for cancer prevention or treatment, there is insufficient reliable information about the clinical effects of B. longum for this condition.
Insufficient Reliable Evidence To Rate Celiac disease
It is unclear if oral Bifidobacterium longum is beneficial for celiac disease.
Insufficient Reliable Evidence To Rate Chemotherapy-related infection
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Clostridioides difficile infection
Although there has been interest in using oral Bifidobacterium longum for C. difficile infection, there is insufficient reliable information about the clinical effects of B. longum for this condition.
Insufficient Reliable Evidence To Rate Cognitive function
It is unclear if oral Bifidobacterium longum is beneficial for improving cognitive function.
Insufficient Reliable Evidence To Rate Colic
Although there has been interest in using oral B. longum for colic, there is insufficient reliable information about the clinical effects of B. longum for this condition.
Insufficient Reliable Evidence To Rate Common cold
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Constipation
It is unclear if oral Bifidobacterium longum is beneficial for constipation.
Insufficient Reliable Evidence To Rate Coronavirus disease 2019 (COVID-19)
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Crohn disease
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Depression
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Diabetes
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Familial hypercholesterolemia
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Generalized anxiety disorder (GAD)
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Helicobacter pylori
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Hepatic encephalopathy
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Infant mortality
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Insomnia
It is unclear if oral Bifidobacterium longum is beneficial for improving sleep quality.
Insufficient Reliable Evidence To Rate Irritable bowel syndrome (IBS)
Although most research shows that taking Bifidobacterium longum in combination with other probiotics is beneficial for IBS, the effect of B. longum alone is unclear.
Insufficient Reliable Evidence To Rate Japanese cedar pollinosis
It is unclear if oral Bifidobacterium longum is beneficial for this condition.
Insufficient Reliable Evidence To Rate Lactose intolerance
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Metabolic dysfunction-associated steatohepatitis (MASH)
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; it is unclear if it is beneficial when used alone for MASH, previously called nonalcoholic steatohepatitis (NASH).
Insufficient Reliable Evidence To Rate Metabolic dysfunction-associated steatotic liver disease (MASLD)
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; it is unclear if if is beneficial when used alone for MASLD, previously called nonalcoholic fatty liver disease (NAFLD).
Insufficient Reliable Evidence To Rate Necrotizing enterocolitis (NEC)
It is unclear if oral Bifidobacterium longum is beneficial or safe for NEC prevention.
Insufficient Reliable Evidence To Rate Obesity
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Oral mucositis
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Periodontitis
Although there has been interest in using oral Bifidobacterium longum for periodontitis, there is insufficient reliable information about the clinical effects of B. longum for this condition.
Insufficient Reliable Evidence To Rate Postoperative infection
It is unclear if oral Bifidobacterium longum is beneficial for preventing postoperative infections.
Insufficient Reliable Evidence To Rate Psoriasis
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Radiation-induced diarrhea
Although there has been interest in using oral Bifidobacterium longum for radiation-induced diarrhea prevention, there is insufficient reliable information about the clinical effects of B. longum for this condition.
Insufficient Reliable Evidence To Rate Respiratory tract infections
It is unclear if oral Bifidobacterium longum is beneficial for preventing respiratory tract infections.
Insufficient Reliable Evidence To Rate Retinopathy of prematurity
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Rotaviral diarrhea
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Schizophrenia
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Sepsis
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Stress
It is unclear if oral Bifidobacterium longum is beneficial for stress.
Insufficient Reliable Evidence To Rate Ulcerative colitis
It is unclear if oral Bifidobacterium longum is beneficial for ulcerative colitis.
Insufficient Reliable Evidence To Rate Vaginal candidiasis
Oral Bifidobacterium longum has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.
Safety & precautions
For most healthy people, Bifidobacterium longum is considered generally safe and is widely used in foods and supplements. However, some groups should be more careful.
People with weakened immune systems, those who are critically ill, who have central venous catheters, or who have recently had major surgery should talk to a doctor first, because rare serious infections from probiotics have been reported in such cases.
For pregnancy and breastfeeding, probiotics are often considered low risk, but high-quality safety data are limited. Because of this, we recommend using B. longum only with the guidance of your doctor during these times.
Always choose products from reputable manufacturers, and check with your pharmacist if you are unsure whether it is right for you.
Side effects
Side effects are usually mild. The most common ones include gas, bloating, and mild stomach discomfort, which often settle as your body adjusts.
Serious side effects are rare. In very rare cases, mainly in people who are seriously ill or immune-compromised, probiotic bacteria have been linked to bloodstream or other infections. Stop the product and seek medical care if you develop a high fever, severe abdominal pain, or feel very unwell after starting it.
Bifidobacterium Longum: Reported Adverse Effects
Documented safety reports on Bifidobacterium Longum from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.
Reports by conditionCancer Immunologic
There have been rare cases of Bifidobacterium bacteremia in critically ill infant and adult patients. Various cases of Bifidobacterium longum bacteremia, sometimes presenting as sepsis, have occurred in preterm infants using probiotics. In one case report, a 15-month-old female infant with congenital heart defects and recent surgery to replace a mechanical heart valve developed Bifidobacterium sepsis after being treated with IV antibiotics, extracorporeal membrane oxygenation (ECMO), and oral probiotics containing B. longum. It was thought that ECMO contributed to translocation of bifidobacteria from the gut and into the blood. In 5 cases, very-low birthweight preterm infants developed B. longum bacteremia following the use of a specific probiotic product providing B. longum and Lactobacillus acidophilus (Infloran) for the prevention of necrotizing enterocolitis; antibiotic treatment was required in at least some of the cases. Cases of sepsis related to B. longum have also occurred in adults; however, association with supplementation is unlikely. In one case, sepsis with B. longum occurred following acupuncture. This was likely due to needle contamination and not to supplementation. In another case, a 71-year-old male with liver cirrhosis and prostate cancer developed B. longum lumbar vertebrodiscitis. The source was thought to be translocation from the intestine. A 42-year-old male developed B. longum peritonitis secondary to intestinal perforation.
- Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
- Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7)
- US Food and Drug Administration (FDA). Dear Healthcare Provider Letter: Warning Regarding Use of Probiotics in Preterm Infants. September 2023. Available at: https://www.fda.gov/media/172606/download?attachment. Accessed November 1, 2023.
- Pillai A, Tan J, Paquette V, Panczuk J. Does probiotic bacteremia in premature infants impact clinically relevant outcomes? A case report and updated review of literature. Clin Nutr ESPEN. 2020;39:255-259.
- Zbinden A, Zbinden R, Berger C, Arlettaz R. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015;107(1):56-9.
- Bertelli C, Pillonel T, Torregrossa A, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015;60(6):924-7.
- Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Støen R, Klingenberg C. Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics. Emerg Infect Dis 2016;22(9):1664-6.
- Ha GY, Yang CH, Kim H, Chong Y. Case of sepsis caused by Bifidobacterium longum. J Clin Microbiol 1999;37:1227-8.
- Wilson HL, Ong CW. Bifidobacterium longum vertebrodiscitis in a patient with cirrhosis and prostate cancer. Anaerobe 2017;47:47-50.
- Tena D, Losa C, Medina MJ, Sáez-Nieto JA. Peritonitis caused by Bifidobacterium longum: case report and literature review. Anaerobe 2014;27:27-30.
Constipation Gastrointestinal
When taken orally, abdominal discomfort, pain, and distension have been reported rarely. Flatulence has been reported rarely with Bifidobacterium longum when used alone or in combination with other species of probiotics. Other rare gastrointestinal side effects have included constipation and gastrointestinal motor disorder.
- Sabaté JM, Iglicki F. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. World J Gastroenterol 2022;28(7):732-744.
- Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007;52(11)
- Sangkanjanavanich S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, Boonpiyathad T. Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial. Ann Allergy Asthma Immunol 2022;129(6):790-792.
- Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial
Cough Pulmonary/Respiratory
When taken orally, a dry cough has been reported by a single patient in a clinical trial.
Adverse-effects data: Natural Medicines, Therapeutic Research Center
Dosing
There is no single established 'correct' dose for Bifidobacterium longum. Probiotic doses are usually measured in colony-forming units (CFU), and products vary widely in how many CFU they contain and which strains they include.
The best approach is to follow the directions on your specific product's label. Because the right amount depends on the strain and the reason you are using it, ask your pharmacist or doctor for advice. Keep the product stored as directed (some need refrigeration) to keep the bacteria alive and effective.
Bifidobacterium Longum & Pregnancy
Bifidobacterium Longum & Breastfeeding
© 2026 Therapeutic Research Center
Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center
References & further reading
The 21 references that drive our Bifidobacterium Longum monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Ha GY, Yang CH, Kim H, Chong Y. Case of sepsis caused by Bifidobacterium longum. J Clin Microbiol 1999;37:1227-8.
- Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
- Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336-42. PubMed
- Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130(6):1355-60. PubMed
- Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
- Pellonperä O, Vahlberg T, Mokkala K, et al. Weight gain and body composition during pregnancy: a randomised pilot trial with probiotics and/or fish oil. Br J Nutr. 2020 Nov 4:1-11. PubMed
- Pellonperä O, Mokkala K, Houttu N, et al. Efficacy of fish oil and/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: A randomized, placebo-controlled, double-blind clinical trial PubMed
- Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial PubMed
- Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
- Enomoto T, Sowa M, Nishimori K, et al. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int 2014;63(4):575-85. PubMed
- US Food and Drug Administration (FDA). Dear Healthcare Provider Letter: Warning Regarding Use of Probiotics in Preterm Infants. September 2023. Available at: https://www.fda.gov/media/172606/download?attachment. Accessed November 1, 2023.
- Pillai A, Tan J, Paquette V, Panczuk J. Does probiotic bacteremia in premature infants impact clinically relevant outcomes? A case report and updated review of literature. Clin Nutr ESPEN. 2020;39:255-259. PubMed
- Sabaté JM, Iglicki F. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. World J Gastroenterol 2022;28(7):732-744.
- Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007;52(11) PubMed
- Zbinden A, Zbinden R, Berger C, Arlettaz R. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015;107(1):56-9.
- Tamaki H, Nakase H, Inoue S, et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial. Dig Endosc 2016;28(1):67-74.
- Bertelli C, Pillonel T, Torregrossa A, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015;60(6):924-7. PubMed
- Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Støen R, Klingenberg C. Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics. Emerg Infect Dis 2016;22(9):1664-6.
- Tena D, Losa C, Medina MJ, Sáez-Nieto JA. Peritonitis caused by Bifidobacterium longum: case report and literature review. Anaerobe 2014;27:27-30. PubMed
- Sangkanjanavanich S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, Boonpiyathad T. Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial. Ann Allergy Asthma Immunol 2022;129(6):790-792. PubMed
- Wilson HL, Ong CW. Bifidobacterium longum vertebrodiscitis in a patient with cirrhosis and prostate cancer. Anaerobe 2017;47:47-50. PubMed
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Brands that make products with Bifidobacterium Longum
578 brands in our database make a supplement containing Bifidobacterium Longum.
Supplement products with Bifidobacterium Longum
3,231 products in our database contain Bifidobacterium Longum. Open any to see its full ingredient list and every drug interaction we check.
Bifidobacterium Longum: Common Questions
What is Bifidobacterium Longum used for, and does it work?
Does Bifidobacterium Longum interact with prescription medications?
How are Bifidobacterium Longum interactions rated?
Is it safe to take Bifidobacterium Longum with my medications?
Where does this Bifidobacterium Longum interaction information come from?
What is Bifidobacterium Longum used for?
Is Bifidobacterium Longum safe to take?
Can I take it while pregnant or breastfeeding?
Does Bifidobacterium Longum need to be refrigerated?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Products that contain Bifidobacterium Longum
A rotating sample of real supplements in our database that list Bifidobacterium Longum — open any to see its full ingredients and every drug interaction we check.
- Skinny Gut Ultimate Shake Natural Vanilla Flavor by Renew Life
- Nickelodeon SpongeBob SquarePants Probiotic + Prebiotic Natural Berry Blast by International Vitamin Corporation
- Energize Greens by Holistic Labs Ltd.
- Digestive Enzymes by Zenwise Health
- Probiotic by TransFormation Professional Protocol
- Probiotic Complex by Aerobic Life
- Maxima by Pure Essence PureBiotics
- Biomuve by Houston Enzymes
- Raw Superfoods Antioxidant Blend Fruit Berry Flavor by Herbal Secrets
- Primary Detox by Bioray
Have a question about Bifidobacterium Longum?
Our pharmacists answer your medication & supplement questions — free.